Zimmer Biomet Holdings Inc (NYSE: ZBH) has reported earnings for its third fiscal quarter (ending September 30) of $1.23 versus $0.78 for the same period a year ago — an increase of 58%. For the latest four quarters through September 30, E.P.S. were $5.27 versus $2.27 for the same period a year ago — an increase of 132%.
Recent Price Action
Zimmer Biomet Holdings Inc (NYSE: ZBH) stock enjoyed a very large increase of 5.7% on 10/30/24. The shares closed at $109.81. Moreover, exceptionally high trading volume at 217% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 5.3% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, ZBH is expected to continue to be an important Value Builder.
Zimmer Biomet Holdings has a current Value Trend Rating of D (Negative). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Zimmer Biomet Holdings has a neutral Appreciation Score of 48 and a slightly negative Power Rating of 33, with the Negative Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment